Loading...
XKRX
000020
Market cap91mUSD
Jul 10, Last price  
5,160.00KRW
1D
3.82%
1Q
-12.24%
Jan 2017
-36.45%
Name

Dongwha Pharm Co Ltd

Chart & Performance

D1W1MN
XKRX:000020 chart
P/E
16.47
P/S
0.29
EPS
313.37
Div Yield, %
3.62%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
12.78%
Revenues
496.39b
+6.78%
148,738,623,000175,119,773,000188,607,515,000145,115,173,000215,279,424,000234,561,984,470223,371,996,540220,240,574,700213,472,144,940223,201,285,430237,470,834,800258,881,616,580306,602,589,030307,150,026,000272,075,384,000293,018,112,000340,426,327,000361,108,562,000464,874,735,000496,394,310,000
Net income
8.69b
+56.13%
8,065,194,00021,495,381,00028,518,530,0006,717,401,0005,427,207,00017,679,223,0701,311,240,9201,011,859,7504,937,204,9605,608,652,16026,254,318,41047,009,013,18010,068,506,3809,402,231,00028,507,687,00017,870,405,00020,383,459,00027,438,290,0005,563,245,0008,686,053,000
CFO
15.70b
P
23,185,889,00023,655,312,00031,155,090,00029,920,326,00018,587,828,00046,244,031,85025,226,760,3608,205,110,34013,514,667,97019,833,109,34025,482,187,950-16,519,974,690-4,360,077,74013,284,966,00052,228,225,00036,031,212,00029,220,767,00029,166,608,000-4,003,244,00015,698,717,000
Dividend
Dec 29, 2025180 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dongwha Pharm Co., Ltd. is a South Korean entity primarily engaged in the production and distribution of pharmaceutical goods. The company's diverse offerings include prescription-only medications addressing a wide spectrum of health concerns such as digestive and infectious diseases, cardiovascular and metabolic disorders, inflammatory and respiratory conditions, musculoskeletal and neurological ailments, as well as dermatological and urological issues. Furthermore, they market an extensive selection of over-the-counter (OTC) remedies, covering categories like digestive aids, cold and flu treatments, anti-inflammatory and respiratory solutions, skin care, oral hygiene, liver support, nutritional supplements, tonics, topical pain relief, antihistamines, and remedies for sore throats, among other products. Beyond pharmaceuticals, Dongwha Pharm also ventures into quasi-drugs, health supplements, food and beverage items, and cosmetics. Established in 1897, the firm maintains its headquarters in Seoul, South Korea.
IPO date
Mar 24, 1976
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT